Arthur Tzianabos - Jun 7, 2022 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 05:00 PM
Previous filing
Feb 28, 2022
Next filing
Jun 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Director Stock Option (Right to Buy) Award $0 +21K $0.00 21K Jun 7, 2022 Common Stock 21K $12.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.